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Studies in the fungal pathogen, Cryptococcus neoformans, have shown that loss of GlcCer 
synthase activity results in complete loss of virulence in the mouse model. However, whether the 
loss of virulence is due to the lack of the enzyme or to the loss of the sphingolipid is not known. In 
this study, we used genetic engineering to alter the chemical structure of fungal GlcCer and 
studied its effect on fungal growth and pathogenicity. Here we show that unsaturation in C8 and 
methylation in C9 is required for virulence in the mouse model without affecting fungal growth in 
vitro or common virulence factors. However, changes in GlcCer structure led to a dramatic 
susceptibility to membrane stressors resulting in increased cell membrane permeability and 
rendering the fungal mutant unable to grow within host macrophages. Biophysical studies using 
synthetic vesicles containing GlcCer revealed that the saturated and unmethylated sphingolipid 
formed vesicles with higher lipid order that were more likely to phase separate into ordered 
domains. Taken together, these studies show for the first time that a specific structure of GlcCer is 
a major regulator of membrane permeability required for fungal pathogenicity.
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1. INTRODUCTION
Cryptococcus species are environmental fungi that are capable of causing life-threatening 
neurological infections. Cryptococcal cells are able to survive and replicate at both neutral 
and acidic pH environments, making them capable of living both intracellularly, inside the 
phagolysosome of infected macrophages, and extracellularly, in the bloodstream (1). 
Invasive cryptococcal infections, primarily caused by Cryptococcus neoformans and 
Cryptococcus gattii, can lead to fungal meningitis, which particularly threatens HIV/AIDS 
patients. Recent studies have shown that sphingolipid pathways play a prominent role in 
regulating the virulence of cryptococcal species. Specific sphingolipid metabolizing 
enzymes regulate cryptococcal growth at acidic and neutral pH, thereby affecting 
cryptococcal virulence (2–4). In addition to C. neoformans, sphingolipids play a role in the 
pathogenicity of other fungi. Sphingolipids regulate hyphal growth and elongation in 
Candida albicans (5,6) and play an important role in germination and hyphal growth of 
Aspergillus fumigatus (7).
GlcCer is a sphingolipid primarily localized in the cell membrane (8). Studies using an 
engineered C. neoformans strain lacking GlcCer synthase 1 (Δgcs1), and thus GlcCer, have 
shown that this mutant is not capable of causing disease because it cannot grow at neutral/
alkaline pH at physiologically relevant CO2 concentrations (2). The native GlcCer structure 
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in fungi is a 9-methyl-4,8-sphingadienine in an amide linkage to 2-hydroxyoctadecanoic 
acid (9,10). Compared to mammalian GlcCer, fungal GlcCer is unsaturated in position 8 and 
methylated in position 9 of the sphingosine backbone. In previous studies, a mutant C. 
neoformans lacking the enzyme that methylates ceramide (Δsmt1), and thus accumulating 
unmethylated GlcCer, showed a partial growth defect at neutral/alkaline pH at 
physiologically relevant CO2 concentrations and a significant attenuation in its ability to 
establish virulence in the mouse model (11). These studies suggest a connection between 
GlcCer structure and cryptococcal virulence, the exact mechanisms of which are yet 
unknown.
In this study, we deleted the enzyme that desaturates ceramide in position 9 of the 
sphingosine backbone and studied the effect of this mutation on cryptococcal virulence. The 
biophysical properties of synthetic membranes containing purified GlcCer, or total lipid 
extracts from the wild-type, Δsmt1, and Δsld8 mutants were also studied. It was observed 
that a cryptococcal strain that accumulates GlcCer with a saturated sphingosine backbone at 
position 8 (Δsld8) completely loses its ability to establish virulence in the mouse model 
without showing a defect in its growth profile or common virulence factors. An increased 
sensitivity to membrane stressors and increased permeability of the plasma membrane was 
also observed resulting in a significant defect in intracellular growth and fungal 
pathogenicity. Biophysical characterization of vesicles containing purified wild-type or 
mutated forms of GlcCer revealed changes in membrane biophysical properties of synthetic 
vesicles. These observations demonstrate that the chemical structure of GlcCer is an 
important regulator of fungal pathogenicity and changes in GlcCer chemical structure alter 
membrane physical properties.
2. EXPERIMENTAL PROCEDURES
2.1. Strains, plasmids and growth conditions
C. neoformans var. grubii H99 (serotype A), also referred to as wild-type (WT) (kind gift 
from Dr. John Perfect, Duke University), was used in this study to generate the mutant 
strains. The Δsmt1 strain and its reconstruct were engineered from this strain as previously 
described (11). The Δsld8 strain was generated using the same wild-type strain, and SLD8 
was reconstituted back into the Δsld8 background (sld8+SLD8). Escherichia coli strain 
DH5α (Invitrogen, Carlsbad, CA) was used for all plasmid propagations. Plasmids pCR 2.1- 
TOPO (Invitrogen) and pBluescript SKII (Stratagene, San Diego, CA) were used as recipient 
vectors for the sld8 deletion and reconstitution cassettes, respectively. Yeast Peptone 
Dextrose (YPD) (BD Biosciences, San Jose, CA) was used for routine propagation of strains 
at 30 °C. YPD supplemented with nourseothricin or hygromycin was used to select for 
transformants (see sections 2 and 3). Yeast Nitrogen Base (YNB) containing all amino acids 
and 2% dextrose (BD), buffered with HEPES or succinic acid (Sigma-Aldrich, St. Louis, 
MO) was used for spot assays. Dulbecco’s Modified Eagle Media (DMEM) buffered with 
HEPES at pH 4.0 and 7.4 was used for monitoring growth curve. Laura-Bertani (LB) 
medium supplemented with 50 μg/mL ampicillin (Sigma) was used for plasmid propagation.
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2.2. Deletion of SLD8
The SLD8 gene locus (CNAG_03870.2) is located on chromosome 2. The deletion cassette 
was generated as described in Supplementary Figure 2A, containing 922 bp of the 5′ 
untranslated and 889 bp of the 3′ untranslated regions. H99 genomic DNA was used as the 
template for PCR amplification of the 5′UTR and 3′UTR. Amplified products were 
individually cloned into the pCR 2.1 vector (Invitrogen) following the manufacturer’s 
instructions and confirmed by restriction enzyme and sequence analyses. The 5′ UTR was 
then released by BamHI and SpeI digestion and cloned upstream of the nourseothricin acetyl 
transferase 1 gene conferring resistance to the antibiotic nourseothricin (Werner BioAgents, 
Germany), in pTOPO (pTOPO-NAT1).(12,13) Similarly, the 3′UTR was released by EcoRV 
and XhoI digestion and introduced downstream of the NAT1 gene in the pTOPO-5′UTR-
NAT1 vector to generate the final vector pΔsld8. The wild-type strain was used as a recipient 
for biolistic delivery of pΔsld8(14) and transformants were selected on YPD plates 
containing 100 μg/mL nourseothricin. Resulting transformants were picked and purified by 
serial passage over YPD nourseothricin plates. Genomic DNA was isolated from the 
transformants and southern blot analysis was carried out using probes specific for either the 
5′UTR, NAT1, or SLD8 ORF.(15) Transformant 61, showing the deletion of the SLD8 ORF 
and the presence of the NAT1, was named the Δsld8 strain and selected for future analyses.
2.3. Reconstitution of SLD8
SLD8 was reconstituted back into its locus in the Δsld8 strain. A 3909 bp fragment of SLD8 
containing the 2128 bp of the ORF and 1383 bp of the 5′ and 398 bp of the 3′ UTR was 
amplified from genomic DNA and introduced into pSK vector carrying the hygromycin 
resistance gene under the cryptococcal actin promoter to generate pSK-SLD8-HYG. This 
was biolistically delivered into the Δsld8 strain and transformants were selected on YPD 
+ 200 μg/mL hygromycin plates. Genomic DNA was extracted and southern hybridization 
was carried out with SLD8 and HYG1 probes. Reconstituted mutants 2, 5, and 51 were 
analyzed by mass spectrometry and mutant 2 was designated as the Δsld8+SLD8 strain.
2.4. Lipid extraction and mass spectrometry analysis
Sphingolipids were extracted as described earlier (15). YPD cultures were set up from single 
colonies of WT, Δsld8 and Δsld8+SLD8 strains and grown at 30 °C for 22 hours. Cells were 
washed with sterile water, counted and 5×108 cells were taken per tube. Lipids were 
extracted following the methods of Mandala (16) and Bligh and Dyer (17). Aliquots were 
taken out for inorganic phosphate analysis. Mass Spectroscopy analyses were carried out on 
the Thermo Finnigan TSQ7000 triple quadrupole mass spectrometer with electrospray 
ionization as described (18).
2.5. Metabolic labeling of lipids
YPD cultures of WT, Δsld8, Δsld8+SLD8 were counted and resuspended to 5×108 cells per 
tube in the overnight conditioned media. Thirty μCi of 3H-palmitate was added to each tube 
and tubes were incubated for 2 hours at 30 °C. Lipid extractions were carried out as 
described in the previous section and the dried lipids were subjected to alkaline hydrolysis. 
Vacuum dried extracts were resuspended in 2:1 (v:v) chloroform/methanol mixture and 
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resolved by thin layer chromatography against a soy glucosylceramide standard (Avanti 
Polar Lipids, Alabaster, AL) in a 173:75:13 (v:v) mixture of chloroform/methanol/water 
solvent. The plate was dried to evaporate the solvent, placed in a cassette and exposed to 
film.
2.6. In Vitro growth assay
Overnight cultures of WT, Δsld8, Δsld8+SLD8 were grown in YNB at 30 °C. Cultures were 
washed twice with sterile water, counted and diluted to104 cells/mL in DMEM pH 4.0 and 
pH 7.4 buffered with 50 mM HEPES. Aliquots of 200 μL were placed in a 96-well plate in 
quadruplicates and the plate was incubated at 37 °C in the presence of 5% CO2. At 
designated time points, 100 μL aliquots were withdrawn, serially diluted and plated onto 
YPD agar plates. Colony forming units (CFU) were enumerated after 48 hours of incubation 
and used to plot the growth curve.
2.7. Sytox green uptake assay
The Sytox green uptake assay was performed as previously described (11). Briefly, cells 
were grown in YNB at pH 4.0 or 7.4 in a shaker incubator at 37 °C in the presence of 5% 
CO2 for 20 hours. Cells were washed and resuspended in the same media at a concentration 
of 108 cells/mL. Hundred microliters of this suspension was added to a 96 well plate 
containing equal amount of YNB in the presence or absence of NO and H2O2. After 2 hours 
cells were pelleted and medium was decanted. Sytox green (2 mM) in PBS was added to 
each cell and incubated in the dark for 10 minutes. Fluorescence was measured using a 
Spectrofluorometer (Perkin Elmer, Waltham, MA) at an excitation wavelength 488 nm and 
emission wavelength of 535 nm. Fluorescence of the medium was taken as background and 
subtracted from the measured values.
2.8. Spot assay
Overnight cultures of WT, Δsld8, Δsld8+SLD8 and Δgcs1 were set up in either YPD or 
YNB, washed and counted. Five microliters containing 10-fold dilutions of cells starting 
from 105 cells were spotted onto YPD plates containing 0.05% SDS or 0.025% Triton 
X-100. Plates were incubated at 37 °C in the presence of 5% CO2 and growth was monitored 
for 48 h.
2.9. Virulence studies in a mouse model of cryptococcosis
Four-week old female CBA/J mice (Jackson Laboratories, Bar Harbor, Maine) were used for 
virulence studies. Ten mice were used per strain. Mice were anaesthetized with 
intraperitoneal injections of 60 μL ketamine-xylazine mixture containing 95 mg ketamine 
and 5 mg xylazine per kg of body weight. Strains WT, Δsld8 and Δsld8+SLD8 were grown 
for 20 hours in YPD at 30 °C under shaking conditions. Cultures were washed twice with 
PBS, counted and diluted to 2.5×107 cells/mL in PBS. Anaesthetized mice were intranasally 
inoculated with 20 μL (5×105 cells) of each strain. Mice were fed ad libitum and their 
survival was monitored on a daily basis. On signs of sickness, mice were sacrificed by CO2 
inhalation followed by cervical dislocation. All procedures were approved by Stony Brook 
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University Institutional Animal Care and Use Committee and followed the guidelines of the 
American Veterinary Medical Association.
2.10. Tissue burden and histological analysis
The 10 mice that survived infection with the Δsld8 strain were used for tissue burden and 
histological analyses 90 days post-infection. Major organs (lungs, brains, livers, kidneys, and 
spleens) were extracted from five mice and homogenized in 10 mL PBS using a Stomacher 
80 (Seward, United Kingdom) for two minutes at high setting. The homogenates were 
serially diluted and dilutions were plated on YPD. Plates were incubated at 30 °C for 48 
hours and colonies were enumerated. For histological analyses, lungs and brains were also 
extracted from the other five mice, placed in cassettes and fixed for 24 h in 10 % formalin. 
Cassettes were then transferred into PBS and stained with haematoxylin and eosin to 
visualize the host inflammatory response (19), and mucicarmine to stain the C. neoformans 
capsule (20).
2.11. Quantification of secreted GXM
For analysis of GXM secretion, one single colony of each strain was grown in a defined 
minimal media (29.4 mM KH2PO4, 10 mM MgSO4, 13mM glycine, 15 mM dextrose, and 3 
μM thiamine-HCl) for 24 h or 48 h in each temperature: 30 °C, 37 °C, 37 °C with 5% of 
CO2 atmosphere. At each time point, an aliquot was taken and GXM quantification was 
done by ELISA as described by Casadevall and colleagues (21). Briefly, the supernatants 
were diluted 1:50 and 1:100 in a 96-well plate and incubated for 1h at 37 °C. The wells were 
blocked with PBS-BSA 1% for 1 h at 37 °C and then coated with 1 μg/mL of monoclonal 
antibody 18B7 (in PBS-BSA 1%) for 1h at 37 °C. The plate was then washed with PBS-
Tween three times and coated with 50 μL of anti-mouse-horseradish peroxidase (HRP) 
(1:5,000 in PBS-BSA 1%). After incubation at 37 °C for 1h, liquids were discarded and the 
wells were washed with PBS-Tween three times. Fifty microliters of 3,3′,5,5′-
Tetramethylbenzidine (TMB) was then added. Reaction was stopped by adding 50 μL 
sulfuric acid (0.16 M) to each well and readings were performed at 450 nm.
2.12. Urease activity
The rapid urease broth was used as described by Roberts and colleagues(22) with 
modifications. The media was prepared 2× concentrated with 4 g urea, 0.02 g of yeast 
extract, 2 mg phenol red, 0.273 g KH2PO4, 0.285 g Na2HPO4. The media was dissolved in 
100 mL of distilled water, pH adjusted to 6.8, and filtered. To check the urease activity, a full 
loop of yeast cells grown for 48 h at 30 °C on YPD was suspended in 2 mL of distilled 
water. One mL of cells (concentration of 108 cell/mL) in water was added to 1 mL of 2× 
urea broth and incubated at 37 °C with shaking for 1, 3, 4, and 6 hours. The magenta red 
color was considered a positive reaction and orange-yellow color was considered a negative 
reaction. The absorbance was measured at 570 nm every hour and readings over 0.3 were 
considered positive (23).
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2.13. C. neoformans pigmentation assay
The melanization assay was performed in minimal medium agar (15 mM glucose, 10 mM 
MgSO4, 29.4 mM KH2PO4, 13 mM glycine, and 3.0 μM thiamine-HCl plus 2% agar) with 
addition of 1 mM of L-3,4-dihydroxyphenylalanine (L-DOPA). Fungal cells were grown in 
YPD broth for 24 h, adjusted to different cell concentrations (107, 106, 105, and 104 cell/mL) 
and then plated on minimal media agar plates at 30 °C, 37 °C, 37 °C with 5% CO2 for 72 h. 
After this time, the plates with melanized cells were photographed. Laccase activity was 
measured by monitoring the oxidation of 2,2′-azinodi-3-ethyl-benzothiazoline-6-sulfuric 
acid (ABTS) at 450 nm and quantified using Enzymatic Units (EU) (24). The reaction 
mixture contained 1 mM ABTS, 0.5 mM sodium acetate (pH 5.0), and 107 cell/mL of each 
strain in water bath at 37 °C. At each time point, absorbance was measured at 4503nm in a 
spectrophotometer against a suitable blank.
2.14. Calcofluor White staining
The Calcofluor White stain containing 1 g/L Calcofluor White and 0.5 g/L Evans blue was 
purchased from Sigma-Aldrich (St. Louis, MO) and staining was performed according to the 
manufacturer’s instructions. Briefly, cryptococcal cells were grown overnight, washed in 
sterile PBS, and then placed on a clear glass slide. One drop of Calcofluor White Stain and 
one drop of 10% Potassium Hydroxide was added to the cell suspension and allowed to 
incubate for approximately one minute. Imaging was performed using an upright confocal 
fluorescence microscope (Zeiss LSM 510, Zeiss, Thornwood, NY).
2.15. Measurement of phospholipase activity
Lysophospholipase (LPL) activity assay was performed by monitoring the rate of loss of 
radiolabelled 1,2-di[1-14C]palmitoyl-phosphatidylcholine (PC) (30,000 dpm) or 
dipalmitoyl-[2-palmitoyl-9,10-3H(N)] PC (30,000 dpm) after the addition of culture 
supernatant. Lysophospholipase transacylase (LPTA) activity assay was performed by 
measuring the rate of radioblabelled PC production from 1-[14C]palmitoyl-lyso-PC. Both 
assays were performed according to the methods of Chen and colleagues (25) with no 
modifications.
2.16. GlcCer purification
GlcCer purification was performed according to the methods of Rodrigues and colleagues 
with minor modifications (9). Briefly, the wild-type, Δsmt1, and Δsld8 strains were grown in 
1.5 liters YPD (5 flasks of 300 mL each). The cells were washed and counted and their 
lipids were extracted following the methods of Mandala and Bligh and Dyer. Extracted 
lipids were then dissolved in 4 mL of chloroform:acetic acid (99:1 (v:v)) and ran through a 
12 cc, silica, Sep-Pak column (Waters, Milford, MA), which was prewashed with 90 mL of 
chloroform. After running the sample, the column was eluted with 60 mL of acetone. The 
acetone containing lipids of interest was dried in a SpeedVac (Savant™ SPD 2010 Speed 
Vac, ThermoScientific, Pittsburgh, PA) and was subject to base hydrolysis and then 
redissolved in 4 mL of chloroform:acetic acid (99:1) and ran through another pre-washed, 12 
cc, silica, Sep-Pak column. The column was eluted sequentially with the following mixtures: 
chloroform-methanol (99:1, 95:5, 90:10 (v:v)), and methanol alone. Purified GlcCer fraction 
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was obtained in the chloroform-methanol 9:1 (v:v) fraction and its purity and structure was 
confirmed with TLC and mass spectrometry.
2.17. Vesicle preparation
Multilamellar vesicles (MLVs) or large unilamellar vesicles were prepared according to the 
methods of Pathak and London (26). Briefly, lipids from each solution were pipetted into 
glass tubes and dried under nitrogen. To ensure complete mixing, the dried lipids were 
redissolved in 20 μL chloroform and redried under nitrogen. Lipids were then further dried 
under high vacuum for 2 hours, and dispersed in 70 °C phosphate-buffered saline (PBS, pH 
7.4). Final samples contained 100 μM lipids. Large unilamellar vesicles (LUVs) were 
prepared by subjecting MLVs to freeze-thawing and passing through a mini-extruder (Avanti 
Polar Lipids).
2.18. Fluorescence anisotropy
DPH fluorescence anisotropy measurements were made using a SPEX automated Glan-
Thompson polarizer accessory (Horiba Scientific, Edison, NJ). Anisotropy values were 
calculated according to the methods of Bakht and colleagues.(27) Anisotropy as a function 
of temperature was measured for MLV samples containing 0.1 mol % DPH and 100 μM 
lipid. The samples were incubated at room temperature for 1 hour and then cooled to 16 °C. 
Samples were then heated in steps of approximately 4 °C and anisotropy was measured at 
each step once the temperature stabilized.
2.19. Forster resonance energy transfer (FRET)
FRET experiments were performed according to the methods of Pathak and London (26). 
DPH 0.1 mol% was used as donor while rhodamine-DOPE 2 mol% was used as acceptor in 
F samples. The F0 samples contained only unlabeled lipids and FRET donor. Background 
samples for F0 (containing only unlabeled lipid) and for F (containing unlabeled lipid plus 
FRET acceptor) samples were also prepared. Samples were prepared at 70 °C, incubated at 
room temperature for 1 hour, and then cooled to 16 °C. Samples were then heated in steps of 
approximately 4 °C and fluorescence intensity was measured at each step once the 
temperature stabilized. Background fluorescence was also measured and subtracted from the 
FRET sample values. The ratio of fluorescence intensity in the presence of acceptor to its 
absence (F/F0) was calculated. The domain detection midpoint temperature (Tm) was 
calculated for each curve. Tm was defined as a point of maximum slope of a sigmoidal fit of 
F/F0 data.
2.20. Preparation and imaging of giant unilamellar vesicles (GUV)
GUVs were prepared according to the methods of Lin and London (28). Briefly, total lipid 
extracts from cryptococcal cells or a mixture of GlcCer, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine, and ergosterol were dried under N2, and then dissolved in chloroform at a 
concentration of 10 mg/mL. A small volume (1–2 μL) was then spread on ITO-coated 
coverslips. The solvent was then completely evaporated by drying under vacuum for 2 hours. 
The lipid-containing coverslip and a blank coverslip were then positioned in a home-built 
flow chamber at a distance of ~2 mm from each other. Afterwards, 200–300 μL trehalose 
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solution was added to the chamber. Next, a voltage of 1.2 V at 10 Hz was applied for at least 
2 hours at room temperature. GUVs were imaged using Zeiss LSM 510 META NLO Two-
Photon Laser Scanning Confocal Microscope System (Zeiss, Thornwood, NY).
2.21. Vesicle Permeability Assays
LUVs containing 5(6)-carboxyfluorescein (Sigma-Aldrich) were prepared according to the 
method of Zhang and colleagues (29) and were used in vesicle permeability studies. Briefly, 
MLVs were prepared using the methods described above, except that 5(6)-
carboxyfluorescein was dissolved in phosphate-buffered saline (PBS, pH 7.4) at a 
concentration of 80 mM before hydration of the lipids. LUVs were then prepared by 
subjecting the MLVs to 7 freeze-thaw cycles followed by passage through a 100 nm 
polycarbonate filter (Avanti Polar Lipids, Alabaster, AL) 11 times in order to obtain uniform 
vesicle size. Non-encapsulated 5(6)-carboxyfluorescein was removed using a PD-10 
desalting column (GE Healthcare Life Sciences, Pittsburgh, PA). A fresh vesicle solution 
was used for each experiment.
Leakage experiments were performed on a Beckman Coulter DTX880 plate reader with 
excitation and emission wavelength filters of 485 nm and 535 nm, respectively. LUVs were 
incubated in a 96-well quartz microplate at 25 °C. The fluorescence signal of 5(6)-
carboxyfluorescein was continuously measured during the course of each experiment. The 
maximum leakage for totally disrupted vesicles (Fmax) was measured by adding the 
detergent Triton X-100 to a final concentration of 0.2% (vol:vol). The percent leakage is 
calculated from: Percent Leakage = 100 × [F(T) − Fbaseline]/(Fmax − Fbaseline), where 
F(T) is the fluorescence intensity at time T, Fmax is the fluorescence intensity when all of 
the vesicles have been disrupted and Fbaseline is the base line fluorescence observed at time 
zero.
2.22. Statistical Analysis
Animal studies were performed by assigning mice randomly to treatment groups. Group 
sizes were chosen such that a statistical power of at least 80% was reached. No samples or 
animals were excluded from the analysis. The results of mouse survival studies were 
compared for statistical significance using the Student-Newman-Keuls t-test or the Kruskal-
Wallis test. Statistical analysis for tissue burden was performed using the analysis of 
variance (ANOVA). Further statistical analysis were performed using unpaired t tests using 
the GraphPad Prism (La Jolla, CA, USA) software package. All data were reported as mean 
± standard deviation and results were considered significant at P ≤ 0.05.
3. RESULTS
3.1. Growth and virulence profile of the Δsld8 strain
To create a C. neoformans strain with a saturated GlcCer structure the SLD8 gene was 
deleted from the wild-type, C. neoformans H99. Southern hybridization analysis confirmed 
the generation of the Δsld8 mutant strain, which was then used to reintroduce the SLD8 gene 
and create the reconstituted Δsld8+SLD8 strain (Supplementary Figures 1 and 2). Our 
previous studies in engineered C. neoformans strains that did not produce GlcCer (Δgcs1) 
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(2), or produced GlcCer without a methyl group on carbon position 9 (Δsmt1) (11), had 
revealed defects in C. neoformans growth in DMEM at neutral pH, 37 °C, and 5% CO2. 
However, the Δsld8 strain did not show any growth defect in acidic (pH=4) or neutral/
alkaline (pH=7.4) in DMEM at 37 °C, and 5% CO2 (Figure 1A and B), and its growth 
profile was similar to the wild-type and the reconstituted Δsld8+SLD8 strains. The role of 
GlcCer chemical structure in cryptococcal virulence was investigated using in vivo infection 
studies in a mouse model of cryptococcosis. CBA/J mice were infected with 5×105 
cryptococcal cells and their survival was monitored over 90 days. It was observed that while 
the mice infected with the wild-type and the reconstituted Δsld8+SLD8 strains succumbed to 
infection in less than 40 days, all the mice infected with the Δsld8 mutant strain survived the 
infection (Figure 1C). Quantitation of the fungal burden in the lungs and the brain of strains 
infected with the Δsld8, the wild-type, and the Δsld8+SLD8 strains revealed that while all 
strains led to a significant number of colony forming units (CFU) in the lungs, the number of 
CFU of the Δsld8 strain in the lungs were reduced over time (Figure 1D). In addition, the 
Δsld8 strain was unable to establish meningitis as evidenced by a lack of CFUs in the brain 
(Figure 1E). The loss of virulence of the Δsld8 strain in mice was a surprising phenotype, 
given that this strain did not show any growth defects. Therefore, common virulence factors 
of this strain were characterized to elucidate the underlying mechanisms for loss of 
virulence. Analysis of capsule size, cell wall, glucuronoxylomannan (GXM) secretion, 
melanization at different temperatures, urease and laccase activity, and the release and 
activity of phospholipase B1 (Plb1) revealed no significant differences between the Δsld8 
strain and the wild-type (Supplementary Figure 3). Taken together, these analyses suggest 
that the Δsld8 strain is not significantly different from the wild- type in its virulence traits, 
despite being avirulent in the mouse model.
3.2. GlcCer structure regulates plasma membrane permeability and intracellular survival
Since GlcCer is primarily localized at the cell membrane (8), the effects of changes in 
GlcCer chemical structure on plasma membrane permeability and resistance to 
environmental stress were investigated. Plasma membrane permeability was examined using 
a Sytox green uptake assay. Sytox green shows significant increase in fluorescence upon 
binding to nucleic acids and can be used as a measure of membrane permeability (30). Sytox 
green uptake assay at acidic and neutral/alkaline pH revealed a significant increase in the 
uptake of the dye in the Δsld8 strain compared to the wild-type and the reconstituted strains 
(Figure 2A). Interestingly, this increased uptake was observed even in the absence of 
oxidative and nitrosative stressors and was significantly higher in acidic compared to 
neutral/alkaline pH. While oxidative stress by H2O2 did not increase membrane sensitivity, 
nitrosative stress by 1 mM NO resulted in a dramatic increase in Sytox green uptake (Figure 
2A). These results demonstrate that the Δsld8 strain has a more permeable membrane 
compared to the wild-type similar to the increased permeability previously reported for the 
Δsmt1 strain (11). The Δsld8 strain also showed increased sensitivity to ionic (0.05% SDS) 
and non-ionic (0.025% Triton X-100) detergents (Figure 2B), suggesting that changes in 
GlcCer structure lead to defects in the fungal cell membrane.
To further investigate the mechanisms of loss of virulence in the Δsld8 strain, the ability of 
this strain to grow inside the acidic environment of activated macrophages was investigated. 
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To this aim, primary alveolar macrophages were isolated from CBA/J mice and infected with 
opsonized wild-type, Δsld8, or Δsld8+SLD8 strains with a multiplicity of infection (MOI) of 
1 and the ability of intracellular fungal cells to form buds was investigated by counting the 
buds in at least 100 intracellular Cryptococcus cells. While the Δsld8 strain was able to form 
buds intracellularly, its intracellular growth was significantly slower compared to the wild-
type (p=0.0036) and the Δsld8+SLD8 (p=0.0057) reconstituted strains (Figure 2C).
3.3. GlcCer purification and biophysical characterization
Given the changes observed in the cell membrane, biophysical methods were employed to 
further investigate the effects of GlcCer on cell membrane properties. It was hypothesized 
that changes in GlcCer structure affect membrane stability and organization and contribute 
to the attenuated virulence in Δsmt1 and Δsld8 mutant strains. To investigate this hypothesis, 
GlcCer was purified from the wild-type, Δsmt1, and Δsld8 strains using column 
chromatography. The purified lipids were loaded on thin layer chromatography (TLC) plates 
and migrated the same distance as a GlcCer standard purified from soy lipids 
(Supplementary Figure 4). Liquid Chromatography-Mass Spectrometry (LC-MS) analysis 
confirmed the lack of methyl group on carbon position 9 in GlcCer purified from the Δsmt1 
strain, and the lack of methyl group on carbon position 9 and a double-bond in carbon 
position 8, in the Δsld8 strain (Supplementary Figure 4). Purified lipids were used for 
biophysical characterization studies. Vesicles were made out of each purified GlcCer species 
and fluorescence anisotropy was used to investigate lipid order as a function of temperature 
using the lipophilic fluorophore, diphenyl hexatriene (DPH). At low temperature, all GlcCer 
structures showed high anisotropy as is common for lipids that tend to form ordered domains 
(31,32). Reduced anisotropy was observed with increasing temperature; however, different 
GlcCer structures showed differences in temperature dependence. The more saturated 
structures showed higher anisotropy at temperatures close to, or slightly higher than, 
physiologically relevant values (Figure 3A). The temperature at which the lipids transitioned 
from ordered to disordered state (transition temperature or Tm) was found by fitting a 
sigmoidal curve to the anisotropy data and showed a similar dependence on lipid chemical 
structure (Tm=34.7 ± 0.1 °C for GlcCer from the wild-type, Tm=40.7 ± 1.1 °C for GlcCer 
from the Δsmt1 strain, and 43.2 ± 1.1 °C for GlcCer from the Δsld8 strain), suggesting that 
GlcCer from the mutant strains are likely to increase the lipid order in the cell membrane at 
physiologically relevant temperatures.
The tendency of GlcCer structures to promote lipid phase segregation and form ordered 
domains in simple plasma membrane models was investigated by imaging giant unilamellar 
vesicles (GUVs). Mixtures of a high Tm lipid, a low Tm lipid, and a sterol have been 
suggested as a simple model of the plasma membrane (33–38). To mimic the fungal cell 
membrane, a ternary mixture of equimolar concentrations of GlcCer (as the high Tm lipid), 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, as the low Tm lipid), and 
ergosterol (henceforth referred to as G:P:E) was used as a simple model of the plasma 
membrane. Although this system does not mimic the physiological concentration of GlcCer, 
it is close to the level of glycosphingolipids in the lipid rafts of pathogenic fungi (39). GUVs 
were made from the G:P:E mixtures and were doped with 0.01 mol% rhodamine-DOPE, 
which localizes to the disordered lipid phase. Microscopy studies revealed that only the 
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GlcCer purified from the Δsld8 strain formed large ordered domains that could be visualized 
with confocal microscopy (Figure 3B). It should be noted that GlcCer was able to form 
ordered domains in synthetic membrane mixtures with POPC and ergosterol even in its wild-
type, most unsaturated, structure as demonstrated by Förster Resonance Electron Transfer 
(FRET) assays, which can detect submicroscopic domains (Supplementary Figure 5). Thus, 
we conclude the size of the domains in GlcCer purified from the wild-type (and likely the 
Δsmt1 strain) were too small to be observed using microscopy.
3.4. Whole cell lipid biophysical characterization and leakage assay
The increased lipid order and domain formation in vesicles containing pure GlcCer, 
motivated further studies to examine whether changes in lipid order will also be observed in 
whole cell lipid extracts. To this aim, DPH anisotropy was used to examine lipid order in 
vesicles synthesized from whole cell lipid extracts. As expected, all strains showed lower 
anisotropy values at 37 °C compared to 23 °C, as temperature increase is expected to 
increase molecular motion and reduce membrane order (Figure 4A). However, no significant 
differences were observed, at either temperature, in the anisotropy of vesicles synthesized 
from the lipids of different strains, revealing no significant changes in lipid order.
Since an increased uptake of Sytox green was observed in both Δsmt1 (11) and Δsld8 (Fig 
2A) strains, the leakage of the fluorescent dye 5(6)-carboxyfluorescein from inside the 
vesicles was also investigated. The fluorescence of 5(6)-carboxyfluorescein is self-quenched 
at high concentrations. Thus, the fluorescence intensity is reduced when high concentrations 
of this dye are encapsulated inside the vesicles. However, upon release from the vesicles, the 
dilution of the dye results in increased fluorescence, which can be used as a measure of 
leakage from the vesicles (29). To investigate leakage from the vesicles synthesized from 
whole cell lipid extracts, 5(6)-carboxyfluorescein was encapsulated in vesicles made from 
the lipids of the wild-type strain as well as the Δsmt1 and Δsld8 mutant strains. All vesicles 
were allowed to incubate in buffer at pH=7.4 at room temperature and the fluorescence of 
5(6)-carboxyfluorescein was recorded. Experiments up to 24 hours, revealed no differences 
in leakage from the vesicles (Figure 4B), suggesting no changes in membrane permeability 
of the vesicles synthesized from the whole cell extract lipids of different strains. Similarly, 
GUVs synthesized from the whole cell extract lipids did not show large-scale phase 
segregation in any of the strains (Figure 4C).
4. DISCUSSION
The results of the current study suggest that there is a direct connection between the 
unsaturation of the sphingosine backbone in GlcCer and the ability of C. neoformans to 
establish virulence. The connection between GlcCer, saturated at carbon 8 and unmethylated 
at carbon 9, and loss of virulence is not due to changes in common virulence factors, but is 
likely due to changes in membrane properties. While our previous studies demonstrate a 
70% loss of virulence in the Δsmt1 strain that produces GlcCer without a methyl group, the 
current study reveals that the Δsld8, with more saturated GlcCer completely loses its 
virulence despite being able to grow normally at both acidic and neutral/alkaline pH 
environments. This strain also did not exhibit significant changes in common cryptococcal 
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virulence factors such as capsule formation, secretion of GXM, melanization, laccase, Plb1, 
and urease activity.
Several lines of evidence suggest changes in membrane structure in the Δsld8 strain: this 
strain showed increased membrane permeability and increased sensitivity to detergents. 
Interestingly, the membrane permeability of the Δsld8 strain is increased in acidic pH. This 
explains the reduced intracellular growth, as the fungus is subject to acidic environment as 
well as oxidative and nitrosative stressors inside macrophages. The changes in cryptococcal 
cell membrane structure appear to be linked, directly or indirectly, to GlcCer chemical 
structure as both the Δsmt1 and the Δsld8 strains showed increased uptake of Sytox green. 
This is further supported by the observed changes in the Tm of the GlcCer structures 
purified from mutants and the presence of ordered domains in GUVs containing GlcCer 
from the Δsld8 strain (Figure 3). The increased sensitivity to stressors in acidic conditions is 
also important in the context of the extracellular growth of the Δsld8 strain. The pH of 
infected tissue is acidic; thus, the fungus is more likely to be vulnerable to immune response 
extracellularly, in such acidic environment. Taken together, these observations suggest that 
changes in membrane structure, and not necessarily changes in virulence factors, might have 
been the cause for loss of virulence the Δsld8 strain.
It should be noted that the physical behavior of membranes made out of pure cerebrosides 
(either GlcCer or galactosylceramide) as a function of temperature is unusual and complex. 
Prior studies have reported, in addition to solid to liquid melting at very high temperature, 
they from two crystal-like phases, and there is a thermal transition between them that 
depends on the thermal history of the samples (40,41). The melting temperature detected by 
differential scanning calorimetry in these studies was much higher than we have detected for 
GlcCer by DPH anisotropy. This may be because previous studies were carried out in “fully 
hydrated” samples that are in fact mostly lipid by weight, while those in this report were 
carried out in very dilute vesicles, at a lipid concentration over 1000-fold more dilute. 
Interbilayer interactions that may influence lipid behavior are unlikely to be present under 
our conditions. It is unlikely the difference is due to structural differences between Δsld8 
mutant GlcCer and mammalian GlcCer, as, we see similar DPH anisotropy vs. temperature 
for these species (data not shown). In any case, it is the difference between thermal transition 
temperatures of different GlcCer species in the wild type and mutants, and not absolute 
transitions temperatures, that is of most interest in this study.
Changes observed in the biophysical properties of GlcCer-containing vesicles, depending on 
GlcCer structure, were not reflected in vesicles synthesized from whole cell lipids of each 
strain (Figure 4A and 4C). The permeability of these strains also remained unchanged 
(Figure 4B), which was not in accordance with the observations using live cells (Figure 2A), 
clearly showing increased membrane permeability. The discrepancy between the in vitro and 
in vivo permeability may be due to the inability of the liposome preparation to reproduce the 
lipid composition of the plasma membrane. In fact, while using whole cell lipids reflects 
changes in the lipid composition of the cell that might have occurred as a result of changes 
in GlcCer pathway, one inherent flaw in biophysical characterization of vesicles synthesized 
from whole cell lipids is that these lipids are “contaminated” by other, intracellular 
membrane lipids and thus the final composition is different from the plasma membrane 
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lipids. It is also possible that changes in GlcCer structure might affect membrane physical 
properties through changes in membrane protein expression and localization We have 
reported previously that changes in the chemical structure of cryptococcal GlcCer leads to 
significant changes in the expression of six membrane-localized proteins, especially iron and 
sugar transporters (42). It is possible that another mechanism exists: GlcCer structure leads 
to minor changes in membrane biophysical properties, detected in synthetic but not in whole 
cell extract vesicles, and these minor changes affect the expression and/or localization of 
these or other transporter proteins leading to the disruption of transmembrane signaling 
complex.
While avirulent mutants of C. neoformans have been constructed before, the loss of 
virulence has been associated with an inability to grow at certain conditions (2,3), changes in 
virulence factors (43), or accumulation of immunomodulatory compounds (44). The Δsld8 
strain generated in this study does not show any evidence of the previously found 
mechanisms for loss of virulence, but is more sensitive to oxidative and nitrosative stress and 
is likely to have altered plasma membrane biophysical properties. Increased sensitivity to 
stressors and changes to membrane properties can both contribute to changes in virulence. 
Increased membrane sensitivity, particularly in acidic conditions, can lead to defective 
growth in the intracellular environment, such as that seen in Figure 2C, allowing the immune 
system to contain the infection in the lungs. In addition, increased sensitivity to nitric oxide 
will reduce the ability of the fungus to survive inside the macrophages. This will strip the 
fungus of the possibility to utilize the macrophages as a “Trojan Horse” for extrapulmonary 
dissemination. The Trojan Horse mechanism is known to contribute to cryptococcal 
infection of the brain (45). We have previously shown that depletion of alveolar 
macrophages reduces the dissemination of the fungal cells to the central nervous system 
following intranasal infection, further confirming this mechanism (46). Alternatively, it is 
also possible that increased order and thus rigidity of the plasma membrane, as suggested by 
anisotropy and GUV imaging experiments, can result in loss of virulence by affecting the 
ability of fungal cells to travel through the capillaries in the body. This hypothesis is 
supported by parallels observed in Gaucher disease, caused by accumulation of mammalian 
GlcCer in red blood cells (47). In Gaucher disease, abnormal cell shapes are observed in red 
blood cells (48). These abnormal shapes are a result of GlcCer accumulation and cells regain 
their normal shape after treatment with glucocerebrosidase, which restores normal GlcCer 
levels. GlcCer accumulation and morphological changes in red blood cells have been 
suggested to hamper cell deformability, which prevents the circulation of red blood cells in 
capillaries (48). The structure of the GlcCer accumulated in the Δsld8 strain is identical to 
the saturated, mammalian GlcCer, which accumulates in red blood cells in Gaucher disease 
(49). It is likely that the accumulation of a “mammalian” GlcCer on fungal membrane leads 
to a rigid membrane, which cannot sufficiently deform to travel through the capillaries and 
enter brain microvasculature, thereby preventing the establishment of a virulent and invasive 
cryptococcosis. Fungal burden studies revealed the presence of fungal cells in the lungs, but 
not in the brain, suggesting that the pathogen is unable to infiltrate the brain. Being unable to 
travel within the microvasculature, the Δsld8 is captured by macrophages where it cannot 
survive due to the leakiness of its membrane, leading to the loss of pathogenicity.
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• C. neoformans strain (Δsld8) producing saturated glucosylceramide was 
generated.
• The Δsld8 strain loses its ability to establish virulence in the mouse model.
• Glucosylceramide from Δsld8 forms more ordered vesicles compared to the 
wild-type.
• The plasma membrane of the Δsld8 strain is hyper-sensitive to stressors.
• Changes in glucosylceramide affect virulence by affecting membrane 
properties.
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Figure 1. The Δsld8 strain does not show a growth defect at acidic or neutral pH, but is 
completely avirulent
The mutant and wildtype strains were examined for their growth profile in DMEM at A) 
pH=4.0 and B) pH=7.4 at 37 °C in the presence of 5% CO2. Growth was assayed by 
drawing 100 μL aliquots, serial dilution, and plating on YPD agar to enumerate CFU (three 
independent experiments were performed for each growth condition). C) Four weeks old 
immunocompetent CBA/J mice were infected with wild-type, Δsld8, and Δsld8+SLD8 
mutant strains and monitored for survival (10 were used per strain). Mice infected with the 
wild-type and reconstituted strain succumbed to the infection in an average of 25.5 and 31.5 
days, respectively. Mice infected with the Δsld8 strain remained alive for the duration of the 
experiment (90 days post infection, p value=0.0001). Fungal burden was quantified in D) the 
lungs and E) the brain of five mice per condition. The fungal burden values were statistically 
significantly different compared to the wild-type (shown by *) or the reconstituted strain 
(shown by $). A p-value of 0.05 was used for all analysis.
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Figure 2. The Δsld8 mutant strain exhibits increased membrane sensitivity and reduced ability to 
survive inside alveolar macrophages
A) Fluorescence intensity of Sytox Green after exposing Cryptococcus cells to the dye in 
acidic (left) or neutral/alkaline pH conditions (right) under oxidative or nitrosative stress 
(average of three experiments). B) Five microliter spots of serial dilutions starting from 105 
cells were placed onto YPD agar plates with or without 0.05% SDS and 0.025% Triton 
X-100. Plates were incubated at 37 °C in the presence of 5% CO2 and growth monitored 
(representative images from three experiments). C) Intracellular growth of the wild-type 
(WT), Δsld8, and Δsld8+SLD8 strains inside primary alveolar macrophages from CBA/J. 
Two hours post-infection, the cells were washed, fixed with ice-cold methanol, stained with 
the Giemsa stain for microscopy analysis. A minimum of 100 internalized cryptococcal cells 
was analyzed for budding to calculate intracellular growth (%). Experiments were performed 
a minimum of three times and statistical analysis were performed to determine whether 
changes observed in experiments with the mutant strain were statistically significant 
compared to the wild-type (shown by *) or the reconstituted strain (shown by $). A p-value 
of 0.05 was used for all analysis.
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Figure 3. Biophysical characterization of vesicles containing fungal GlcCer
A) Fluorescence anisotropy vs. temperature of synthetic vesicles composed of GlcCer from 
the wild-type (left), Δsmt1 (middle), and Δsld8 strains (right). A sigmoid function was fit to 
the anisotropy profiles and the chain melting temperature (Tm) was defined as the inflection 
point of that sigmoid. Error bars represent the standard deviation from three experiments for 
the wildtype and two experiments for the mutant strains. B) Images of giant unilamellar 
vesicles (GUVs), synthesized from GlcCer, POPC, and ergosterol (Erg), in a 1:1:1 molar 
ratio. GlcCer purified from the wild-type strain (left), Δsmt1 strain (middle), and Δsld8 
strain (right) was mixed with equimolar concentrations of POPC and Erg. Rhodamine-
DOPE (0.01 mol%), localizing in disordered lipid phases, was used as the fluorescence 
probe.
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Figure 4. Biophysical characterization of vesicles synthesized from total lipid extracts
A) Fluorescence anisotropy of synthetic vesicles composed of total lipid extracts from the 
wild-type, Δsmt1, Δsld8 strains, and their respective reconstructs at 23 °C and 37 °C. B) 
Time-course of carboxyfluorescein leakage from synthetic vesicles composed of total lipid 
extracts from the wild-type, Δsmt1, Δsld8 strains, and their respective reconstructs in PBS 
buffer, pH 7.4 at room temperature. C) Images of GUVs, synthesized from total lipid 
extracts from the wild-type, Δsmt1, Δsld8 strains. Rhodamine-DOPE (0.01 mol%), 
localizing in disordered lipid phases, was used as the fluorescence probe.
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